QuickView for SCN4B;jsessionid=4ECACABF015DD573F5A76D256AED71AA;jsessionid=6EFCB520198C304CB4705735746A6054;jsessionid=261306D5E7A65DF86F483F20FFCDDF74 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Putamen
Caudate
Accumbens
Dorsal root ganglia
Trigeminal ganglia

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Huntington's disease
Disorder of basal ganglia
Bovine respiratory syncytial virus disease
Injury of musculoskeletal system
Movement disorder

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

valacyclovir
DIG-mithramycin SK
Glycine
Methylcholanthrene
loxoprofen

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

MIR181A1
MIR181B1
POM121
VEGFB
HTT

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

SCN4B inhibits the progression of lung adenocarcinoma and is associated with better prognosis.
Scn4b regulates the hypnotic effects of ethanol and other sedative drugs.
Anti-NSCLC role of SCN4B by negative regulation of the cGMP-PKG pathway: Integrated utilization of b…
The Voltage-Gated Sodium Channel Beta4 Subunit Maintains Epithelial Phenotype in Mammary Cells.
The Sodium Channel B4-Subunits are Dysregulated in Temporal Lobe Epilepsy Drug-Resistant Patients.

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for SCN4B;jsessionid=4ECACABF015DD573F5A76D256AED71AA;jsessionid=6EFCB520198C304CB4705735746A6054;jsessionid=261306D5E7A65DF86F483F20FFCDDF74

Explore Clinical Trials Results